CHU Rennes - Hopital Pontchaillou

Rennes, Ille-et-Vilaine 35033

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer's Disease, Atypical Parkinsonism, Brain Edema, Hemophilia A, Neurodegenerative Diseases, PSP, Parkinson Disease, Progressive Supranuclear Palsy, Relapsing-Remitting Multiple Sclerosis, Stroke, Acute

Studies at this site

• A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 — Completed
• Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• AMX0035 and Progressive Supranuclear Palsy — Completed
• A Study of BAX 888 in Male Adults With Severe Hemophilia A — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale — Stopped early
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• BAX 855 PK-guided Dosing — Completed